Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

TGA Approval

FEXODIN 180 fexofenadine hydrochloride 180 mg tablet blister pack (289012)

ARTG ID

289012

ARTG Name

FEXODIN 180 fexofenadine hydrochloride 180 mg tablet blister pack

Sponsor

Nova Pharmaceuticals Australasia Pty Ltd

ARTG Date

May 16, 2017

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Nova Pharmaceuticals Australasia Pty Ltd

Sponsor Item Name

NOVA PHARMACEUTICALS AUSTRALASIA PTY LTD

Active Ingredients

Ingredient Name

fexofenadine hydrochloride

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

FEXODIN 180 fexofenadine hydrochloride 180 mg tablet blister pack (289012) - TGA 批准文号 | MedPath